959
PŘEHLEDOVÉ425200011151111167232285340403465523580
ČLÁNKY1031200011154107169233293349
/1405200011133
REVIEW1463200011157113173207263347
ARTICLES1835200011158120175208264317372423
Left4253200973878103132
atrium574320097396692112156223
and8143200973984130
atrial961320097386592111150170
fibrillation1148320097214287115134153173212238257302347
in15123200971964
critically1593320097366282109128165204224243281
ill1891320097193858
patients:19653200974686112131172218244277294
from2276320097235195163
echocardiography24563200974077122166204243270315335379425452492538583620
to30933200972770
therapy31803200972772113140179225263
3221020001114388
|342200011126
ANESTEZIOLOGIE4268040010753112155200245290342362425467527586607650
A10988040010753
INTENZIVNÍ1172804001071978123168227276296345405426
MEDICÍNA16198040010770114174195248268328382
/20468040010732
Anest21238040010753101145179208
intenziv235180400107186693136184221240281
Med.26528040010770114164180
2026;37(1):28-352852804001074487128171185230270290330348362406449477518560
/34578040010731
www.aimjournal.cz48358040010765133201214257275349367415463490539579598614654693
Principles4253520015371133175250308348418457516570
of10183520015364112
arrhythmia11533520015362125187259320376449554595660
management183635200153102166242306370428531590663714
in25733520015338114
septic4253660015351112183236276334
shock7823660015351126190249323
In425384001071967
accordance517384001074182120167193241282329370412
with954384001076685112160
the1140384001072876120
20241285384001074487128168
ESC1479384001074284135
guidelines,1640384001074996115163207226244292336369385
atrial205038400107416895114154172
fibrillation224838400107244392119138156174215242260308356
therapy2630384001072876120146187237276
should425398001073380128175193241
be682398001074993
structured79039800107346288135175204252277319368
according1174398001074080118163190237255302350
to1539398001072874
the1628398001072875118
AF‑CARE1762398001075293118172225269311
framework:208839800107245091164207271318344381399
[C2502398001072472
–25893980010745
comorbidity]2649398001074086159207233425412001074967114132159200221
comorbidities661412001073984156203229277295343360387405447479
and1155412001074087134
risk130441200107264476112
factor1431412001072364103132177202
management,16484120010773112158198245288359402449474489
[A2152412001072472
–22394120010744
avoid]2298412001074078124142189213
prevention2525412001074975116156197244269287333380
of425426001074871
ischaemic51142600107195191138177221293311350
stroke87742600107336187133171213
and1106426001074087136
thromboembolism,1257426001072875101147220269317361433482530549567599671686
[R1958426001072469
–20424260010745
rate/rhythm]210242600107276794135167191239276307354426447
symptom2564426001073474147196223268341
reduction425440001072769119166206236254302350
through799440001072876102148196245293
rate111644000107276895137
and1277440001074189138
rhythm1439440001072775113144192265
control,1728440001074086135161187234253268
[E2020440001072466
–21114400010745
evaluation]2180440001074484125144191231258276324372393
ongoing2597440001074896145193212259308
assessment425454001074276109154189223297342391419
[7].8694540010926741019694540010716
In1011454001072069
critically110645400107416888116135176218238256297
ill143045400107193857
patients,1513454001075193121140184233261296312
the1852454001072877122
priority200145400107507897146174193222265
is2293454001071952
stabilisation2371454001073564106157176195214247290317336385435
of2832454001074973
homeostasis:425468001074896170214262296324365398416448463
optimisation913468001074898125143216234267308335353401449
of1387468001074872
volume1484468001074188107154227271
and1780468001074189138
preload,1943468001075077119138186227276291
reduction2259468001072769119166206236254302350
in2635468001071866
catecholamine2726468001074081108150425482001074189137157197271290338382
dosage833482001075098131173223267
(if112648200107244266
vasopressor1218482001074183116165215242285319352400427
support1671482001073481131181231257288
is1985482001071952
required,2063482001072770120168186212255306321
vasopressin2410482001074183116164215242285318352370418
is2854482001071952
considered425496001074085132164181229272297338387
as827496001074072
a9144960010741
second970496001073376116161208256
vasopressor),1241496001074080112159208234276308340387413434447
correction1703496001073985111137178218247265312359
of2077496001074770
electrolytes2162496001074361104144173199244263302332373405
(K+,2582496001072467264449600633126724960010715
Mg²+),2702496001077011814328404960063312869496001072436
provision425510001075077125166185218236285334
of785510001074873
oxygenation,884510001074887130179223272313340359407456472
adequate1382510001074191136186234275302345
analgesia,1753510001074290131150200244278297337353
and2132510001074290140
treatment229851000107285598139166241285334361
of2685510001074973
the2784510001072877121
underlying425524001074896145189216235275294342391
cause842524001074082129162206
of1074524001074872
sepsis1171524001073478128161179212
(source1408524001072456104152179218260
control1694524001074086135162188235255
and1974524001074189139
antibiotic2138524001074189116135184203251278297337
therapy).2500524001072877121147188238277300312
In2838524001071967
clinical42553800107405876123141181222240
practice,681538001074975116156186204244286300
particularly996538001075091116147165205252270310336355394
with1406538001076483110158
excessive1580538001074382121163196228246286329
β₁-stimulation192553800107486895128157175247294313352379397445492
and2433538001074188137
the2586538001072775118
need2720538001074892136185
for42555200107247197
higher546552001074967115163207233
catecholamine803552001074081108150190238286305345418437484528
doses,1355552001074997130173207222
following160155200107247190108156220239287336
the1961552001072875119
aforementioned2104552001074164111138180253297345371390437486529579
stabilisation,270755200107346210315217142556600107193769111138156204252267
the718566001072775119
rate86356600107266794136
control1025566001074086135161187234253
is1304566001071951
more13805660010774122149191
appropriate1597566001074190140166213263289308348375417
than2039566001072876117164
immediate2229566001071992165209259277317343386
rhythm2640566001072775113144192265
control425580001074085132157183228247
[29–31].6865800010925701141602042442639475800010715
The977580001074189132
20211124580001074385125163
SSC1301580001074181130
guidelines1446580001074894112159202220237283326358
emphasise18195800010743115163210249281298329372
that,2206580001072774113139154
after237558000107406292133159
correction2548580001074085111136178218247264311358
of425594001074871
reversible512594001072769110152178212230279298342
causes870594001074081128160204237
and1123594001074189138
minimisation1277594001077392139157230248280322348367414463
of1755594001074872
adrenergic1843594001074190116158206250276323342381
burden,2240594001075098124171215263278
the2534594001072875119
choice2669594001074088136154194236
between425608001075094122189232276324
rate76760800107276895137
and923608001074188137
rhythm1079608001072675113144191264
strategy136260800107346289130156199248288
should1669608001073481129177195244
be1932608001074994
individualised2045608001071866115133174193241288328347365397441491
[32].255460800109267111513826906080010716
The565622001074293137
combination729622001074188163213233282323350370418468
of1223622001074973
ECG1323622001074294148
and1497622001074290141
echocardiography1664622001074486135184226268295344363411462489531581631670
helps2361622001074893113163197
to2585622001072875
target268762200107287097145190218
pharmacotherapy:425636001075098139165240281321368395443488514556605645661
in1108636001071967
conduction1196636001074087136185232273303322370419
disorders,1636636001074968101149176224268295329345
drugs2003636001074975123173206
prolonging2230636001075077124144192241290309356406
the2657636001072877121
PQ27996360010746106
interval42565000107196794136163206248267
should718650001073481130178197246
be990650001075095
avoided,1111650001074180128147196240290305
and1442650001074189139
in1607650001071967
structural170065000107336289137178208256282324343
heart2069650001074892133159190
disease2285650001074968100144185218262
or2573650001074875
severe2674650001073478118162188231
systolic425664001073476111141189210229270
dysfunction722664001075092127153203252294325345394444
(LVEF1193664001072465107151193
<14146640010754
35%),1496664001074587153175190
drugs1713664001075077127177211
with1952664001076686115164
significant2144664001073453103153172197217259301351378
cardiodepressive2550664001074083110160179229280325425678001075077120154187206247290
effects74267800107446795139180210245
(e.g.,101467800107246580129145161
propafenone1202678001074976124174216239283331380429473
and1702678001074189139
diltiazem)186767800107496887115134174212255329350
should2244678001073381130178197247
be2517678001075095
limited.2638678001072038112130159201252268
Conversely,425692001075198146186229255289334353393404
in846692001071967
hypercontractile929692001074887137182209248294343369396438478508527546590
LV,153569200107418191
excessive1643692001074483123165199232250291334
adrenergic1994692001074190116159207251278326344385
stimulation,239569200107346382155202221262289307355404419
or2831692001074875
dynamic425706001074887134174245263302
LVOT742706001073978136175
obstruction,932706001074796128156181228267296314360408422
following136970600107236988105152215233279327
preload1711706001074975116134181221269
optimisation,1995706001074795122140211229260300326344391438452
beta‑blocker2462706001074992119159186235254300340376418443
(BB)–based425720001072470117140187239281315361412
therapy864720001072877122149192242283
is1174720001071952
chosen.1253720001074190139173219268284
In1564720001072069
haemodynamic1660720001074990135210260311352402443518537579
instability,2266720001071967101131173224243263282310354366
urgent2659720001074875125170219246
synchronised425734001073373121160207232278325343375418467
electrical907734001074361104144174199218257297315
cardioversion1238734001073980105152170217256298323356374421468
(ECV)1721734001072464114161188
is1924734001071950
indicated1990734001071865113131170210236278326
[7].23327340010925719724277340010715
ECV2458734001074191138
has2612734001074787119
high2746734001074865113160
success425748001073481121160202236269
rates;71574800107266895137171186
however,921748001074897162205246289315327
in1268748001071967
the1355748001072876121
intensive149674800107196793136184217235276320
care1836748001074081108151
setting,2007748001073478106136155203252268
early2295748001074484110130170
recurrences2485748001072769111158185212255303344386420
(within425762001072486105132180198245
24686762001074483
hours)786762001074795143169202223
are1025762001074167109
common,1150762001074086159232280328343
and1509762001074088136
therefore1662762001072775118144187210257283326
ECV2004762001074292140
is2160762001071951
typically2227762001072769119138178219237255295
combined2538762001074086159208227274318367
with425776001076584112161
an605776001074189
antiarrhythmic714776001074189116134175201228277315347395468487527
agent1261776001074190134182209
[33].149077600109267211613916277760010716
For3187356001074289117
rhythm3330356001072776115146195269
control,3625356001074188137164191238258273
propafenone3925356001075077124175217241284333382431475
(class442735600107246281122155189
Ic)464235600107206084
can4752356001074082131
be4909356001075095
considered5031356001074087136170188238282309352402
in5460356001071967
patients3047370001075193122141186236263299
without3374370001076686115165214264293
significant3694370001073554104153173197218259302352379
structural410137000107346492141183214264291334353
disease4482370001075069103148190224269
(approximately4779370001072464114166194242281301377418447490510552
LVEF5358370001074183127169
≥30473840010754
35%3125384001074485150
and3299384001074189138
non‑dilated3461384001074997146174225243262303330372422
LA),3908384001074095118132
whilst40643840010765114132151184213
amiodarone43013840010741114133181231272298345394438
(class476338400107246280121154188
III)49753840010719385680
is5079384001071952
suitable515538400107338099127168218238282
in5461384001071967
severe3047398001073478118161188231
systolic3294398001073475109138184204222262
dysfunction3573398001074989123148197244285315334382430
and4020398001074189138
structural417539800107336289137178208256282324343
disease4534398001074968100145185218262
(e.g.,481339800107236579128144160
dilated498939800107496887127154197247
LA)5252398001074195119
due5388398001074896140
to3047412001072773
its313641200107184579
minimal3231412001077390137155227267285
cardiodepressive3532412001073980105152170217266309358384426458491508548591
effect413841200107436693135175205
[20,4358412001092570115132
27,450641200109458898
28,4619412001094590109
34].474341200109459111448564120010715
Echocardiography4887412001074180127174214255280327345392441467507556603641
is3047426001071952
also312542600107416093142
useful3293426001074882126150199218
when35384260010765114159207
the3772426001072776121
duration3919426001074997124165193212260309
of4254426001074973
the4353426001072877121
arrhythmia450142600107416795144182214262336355396
is4923426001071952
uncertain.5002426001074896137179206237279298346362
The5391426001074292136
finding304744000107244492142161210260
of3334440001074872
a34334400010741
markedly35014400010774116143182225276295336
dilated386344000107506988129157200250
LA4140440001074196
or4263440001074876
significant4366440001073352102150169194214255297345372
valvular4765440001074183103144193213254280
disease5072440001075069102147187221266
(e.g.,536444000107256682131148163
mitral3047454001077391119145186204
regurgitation/stenosis)3267454001072769118165191239257284325352370417465497527556597645693725743775796
increases4079454001071966106132174214246290323
the4418454001072775118
likelihood455345400107183673116135153200248296345
of4914454001074871
chronic5001454001074087113159207225265
AF5282454001075293
and5391454001074188137
reduces3047468001072770120167208250284
the3348468001072876120
prospect3485468001075077124157206251293323
of3825468001074872
maintaining39144680010773114133181208249268315334382431
SR.4362468001074286104
For4483468001074289116
rate461646800107266895138
control,4771468001074086135162189236255270
BBs5058468001074692124
and5199468001074189138
non­5354468001074897145173
‑dihydropyridine304748200107277896144182231257304354393420439488507554598
calcium3662482001074081100140159206279
channel3957482001074088129177224268287
blockers4261482001074969117158196239265299
(CCBs)4576482001072474122166198219
are4812482001074167109
most49384820010773122155184
commonly5138482001074187161234282331349389
used.3047496001074881125175191
BBs3262496001074691123
(class340949600107246281121155188
II)362149600107193861
are3706496001074167110
particularly3840496001075092118149168208256275315342361401
suitable426549600107348199128169218238282
in4571496001071967
NOAF46624960010757118169210
with4896496001076584112161
hyperkinetic5081496001074886137182208247267315359387406446
circulation304751000107405985124172191231258277325374
where34435100010765114158185228
there3693510001072876121147190
is3906510001071851
excessive3980510001074383122165199232250291334
β₁-adrenergic433751000107496997137187213256304349375423442482
stimulation,484251000107336281154202221261289307355404420
as5284510001074174
well53815100010765108128146
as3047524001074174
in3141524001071967
hypertension3228524001074887138182209240282331364382430478
and3727524001074089138
ischaemic388552400107195292140181225299317358
heart4263524001074892132159190
disease4473524001074967100144184218262
[7].47545240010926739948525240010716
Ultra‑short‑acting4888524001075675103130171199233281329356387412452493523542590639
and3047538001074189138
selective320153800107347897141182212231272315
BBs3532538001074591123
(esmolol,367153800107246599172220240288307322
landiolol)4010538001071959107156175222242290310334
allow436053800107416078126191
titration456753800107284774101143169188236284
of4868538001074872
heart4956538001074892132158189
rate516253800107266895137
whilst53155380010765114132151183212
preserving3047552001075077120153197224268287335385
perfusion.3449552001075095121148197230248296345361
Landiolol3828552001074082130180199247266314334
in4180552001071966
prospective4264552001075077124157206251293323342383426
randomised4708552001072668116165214288306339383433
controlled5159552001074087135162189236256274318368
trials304756600107285574114133166
(J‑Land323956600107245584126168216265
3S,353156600107438399
STRESS‑L,3656566001074285132174217258286328345
LANDI‑SEP)4027566001074095152211230258298339383405
demonstrated4458566001074993167215264297326353394422464514
effective499856600107446895139180210229270313
heart5337566001074993133159190
rate304758000107266794136
control3199580001074086134160186233252
and3467580001074188137
haemodynamic3620580001074888131204252301341390430502521560
safety419658000107347598141168210
without4422580001076584111159207254282
a47205800010740
significant477758000107335199147165188208247288336362
increase5155580001071966106132174214247290
in5461580001071966
vasopressor3047594001074082115163212239282315348396423
support3486594001073481130179228255286
and3788594001074188137
without3942594001076584111159207255283
impaired4242594001071891140182200226269318
perfusion;4577594001074994120147195228246294342356
however,4950594001074896160203244286313324
review5291594001072669109128172236
data3047608001074990117158
showed3224608001073482130195238288
no3532608001074896
short‑term3648608001073381129156187212240282309383
or4050608001074875
long‑term4144608001072068116166194222264291365
mortality45286080010774122149180222241259287330
benefit4877608001075095143187211231259
[29–31].515560800109267211716521025227354266080010716
In5461608001071967
a30476220010740
subgroup3103622001073379127176202248295343
of3462622001074770
intensive354862200107186591133180212229269312
care3875622001074080106148
patients4038622001074990116134177224250284
with4338622001076482109157
NOAF,45106220010757116166206212
a47386220010740
non‑significant4793622001074895143170203221269315333356376415455502528
trend533762200107275395142190
favouring3047636001072466105153201227247295344
landiolol3416636001071959107157175223243291311
was37516360010765107140
described,3916636001074993126167193213262307357373
though4313636001072876125173222270
without4608636001076584112160209257285
proven4918636001075076124164207255
mortality51986360010773122149180221240259287329
benefit3047650001075095143187211230259
[35].332765000109267211614234676500010716
Observational35056500010760110144188215259300327346394443483502
studies4029650001073463111160179223256
suggest4307650001073481130180224257286
an4615650001074189
advantage4726650001074190132173221248289339383
of5131650001074872
BBs5225650001074591123
over5370650001074888131158
other3047664001074876124169195
rate326966400107266896138
control3434664001074087136163190237257
strategies;371866400107336390131159202252271315349364
however,4108664001074997162206247291317329
patient4464664001074991119138182230257
selection474866400107337897142183214233281330
is5104664001071952
crucial.5183664001074067115156175215235250
In5460664001071967
a30476780010741
systematic3105678001073374108137180253294321340380
review3502678001072770110130173238
of3757678001074872
173846678001074480
studies3943678001073463111160179223256
evaluating4216678001074484126145192233260279327376
landiolol4609678001071960108157176224243291311
use4937678001074881125
in5079678001071866
critically516267800107406786114133173215233252292
ill547167800107193756
patients3047692001074989115133175222248281
with3343692001076483109156
atrial351469200107416792111149168
fibrillation,369769200107234290115134152169208234252299346361
landiolol4073692001071958104152170216235282301
demonstrated4389692001074890162209256288316342382408449498
good4902692001074895142191
efficacy510869200107436592110149189229270
and5393692001074086134
tolerability304770600107277392135160201249268286303331372
in3435706001071865
rate351670600107266693134
control3666706001073985132158184230249
as3930706001074173
well40197060010764106124142
as4177706001074072
the4265706001072775118
ability4398706001074089107125143170212
to4625706001072873
induce4714706001071865113160199240
cardioversion4970706001074080105152170217256299324357375422469
to5455706001072773
sinus304772000107345299147179
rhythm3243720001072775113145193266
in3525720001071967
both3608720001075099126174
non‑surgical3799720001074896145173207254280328346387428447
(75.7%)4262720001072468109123166232253
and4532720001074088137
surgical4686720001073480107155173213255274
patients4976720001075091118137180228255290
(70.1%)5282720001072468109125163224245
[36].304773400109267211814231887340010716
Although3224734001075372100148197245294342
the3587734001072876120
data3728734001074989116158
are3906734001074168111
promising,4037734001075077124198217249268315365380
the4438734001072876120
safety457973400107337599142170213
and4812734001074189139
efficacy497173400107446895115155197237280
of5271734001074872
beta5364734001074994122163
blockers3047748001074968115155192234260293
in3356748001071865
NOAF34377480010756116165205
need3658748001074791134183
to3857748001072773
be3945748001074993
further405474800107237196126174217242
validated431274800107408099116164204230272321
in4648748001071966
randomised4729748001072667114162209282300332375424
controlled5168748001074085133159185231250268310359
trials.304776200107285473113132164181
Transthoracic3244762001074263104152185214262310336378418436476
echocardiography3737762001074384132180221262288336355402452478520569617656
can4409762001074081129
serve4554762001073478104148191
as4761762001074174
a48517620010741
fundamental4908762001072472120169210283327375401442461
tool5386762001072774122142
for304777600107247198
selecting316577600107337897141182212231279328
suitable351377600107348199127169218238282
patients3815776001074991118137181229256291
to4125776001072875
initiate421977600107196786114133173200242
BB4481776001074691
therapy.4592776001072876120147188238277289
Tab.425600012561110164190
2.63160001255481
Echocardiographic75761001074076122167205249275318336382428453496541588606643
predictors141761001074571108153171209236280306337
and177161001074591136
thresholds19246100107267297134165210255274319349
for22896100107236793
NOAF2398610010755114160199
Parameter4567500984585115156225267296338367
How108675009854100160
to12637500982873
measure135375009868110151185231261303
/167275009827
When108685009870116159205
Approximate18677500985198146175221261282351392421462
cut-off23467500983682111134182208237
AUROC286275009851103149207255
What353575009870116158186
it37387500982049
indicates38047500982067114135172214242284318
When432375009870116159205
to45457500982873
use46357500984680122
Note490775009854101129171
LAVi4569700953685123141
(ml/m²)6159700952184102131195219242
A4C+A2C,10869700954786134176222262307322
end-systole,108610700953982126151182219249275317335374388
indexed149110700951760104143179218262
≥186797009548
3419329700953979
dilation;2029970095436077114138155198242255
<4023029700954783124
favourable2443970095215995137180204241286304343
for18671070095216488
rhythm197210700952468102130174239
control222910700953577121145169211229
0.532862970095395393130
*(LAVi28621070095315288137174193
>3072107009548
32.9)31371070095407690128148
Risk3535970095405887121
of36749700954264
NOAF/375597009551106151188212
recurrence,35351070095246299142166190229272308346360
strategy39121070095305680118142180225261
selection35351170095306987126163191208251294
Before43239700954080102144169207
ECV45489700953783126
Preloaddependent49079700954063102119163200244490710700954483128168211255295338362
LA45612900953685
ESD55812900953876127
(mm)70312900952184150170
PLAX,108612900954075124170185
end-systole128912900953882126151181218249275317334374
≤1867129009548
45193212900953976
favourable;20261290095215994137180204241286303343356
≥46240012900954886127
weak254512900955796132167
predictor186713900954468107152169205232274298
recurrence21831390095236299142166190229272308346
0.5928621290095395393130
*(LA28621390095315288137
ESD301613900953776127
>3160139009548
44)322513900953981101
SR353512900953777
maintenance3629129009566102119162186225268304347384422
after40681290095375886124148
ECV353513900953783126
Before432312900954080102144169207
ECV454812900953783126
One-dimensional490712900955498137163209226292331375404421464507544561
LAEF45615100953685122159
(%)6331510095217998
Biplanar108615100954058102120156199236259
in136315100951760
SR/after144015100953777108142164192230254
ECV108616100953783126
>1867151009548
38193215100953978
0.6928621510095395393131
*(LAEF28621610095315288137174211
>3090161009548
38.4)31551610095407894132152
SR353515100953777
maintenance3629151009566102119162186225268304347384422
After43231510095476896134158
ECV449915100953783126
Functional490715100953778121158185202245289325342
indicator490716100951760104121157194219260285
AVTI45617300954784127145
(cm)61817300952255121141
VTI108617300954183101
of120517300954264
A-wave128617300954771130167203242
in154517300951760
SR162217300953877
>1867173009548
6.819321730095395495
0.6528621730095395393131
*(AVTI28621830095315299136178197
>3076183009548
6.8)31411830095395495115
SR353517300953777
maintenance3629173009566102119162186225268304347384422
Atrial35351830095477195112148166
contraction371818300953678121145170207243271288331374
strength35351930095305680119162206232275
After43231730095476896134158
ECV449917300953783126
Not490717300955195119
assessable50441730095366696136166196233278296335
in539717300951659
NOAF4907183009551105151188
E/e’45620500953768104118
(–)5922050095216079
septal68920500953069114139176193
PW+TDI,1086205009540106152184237255269
SR137320500953776
or146720500954367
regular155120500952462107150167204227
NOAF1086215009551105151188
HR129121500955191
≤1400215009548
100146521500953975116
>1867206009548
11193220600953970
↑LAP20202060011938205720600953685125
/2200206009528
NOAF2245206009551106151188
–2862205009540
Elevated35352050095375494130167192230275
filling382720500952139567390133177
pressures353521500954468107137167209233272302
Before432320500954080102144169207
&4548205009544
after46102050095365886124148
ECV432321500953783126
Consider490720500954687131161177221261285
HR/520920500955191122
rhythm490721500952467102130173239
TR45622700953779
Vmax553227009540105142177
(m/s)74822700952185114142161
CW1086227009546113
across12172270095367397139169199
TR143322700953879
>1867227009548
2.819322270095395394
–2862227009540
↑sPAP35352280011938356822800953070112153
/3738228009528
RV378422800954082
strain38832280095305680118134177
Before432322700954080102144169207
ECV454822700953783126
Supports490722800953779124169213237265296
↑LAP52212280011938525922800953685125
LVEF45624000953672111148
(%)6212400095217999
Simpson108624000953754119164194237281
biplanar138424000954462106124160203240264
A4C/A2C108625000954786134164206247292
<1867240009548
35193224000953977
–2862240009540
AA353524000954796
choice364824000953679122140176214
(amiodarone)353525000952156121138181226263287329372412432
Before432324000954080102144169207
treatment43232500095254987123148214254297321
Treatment49072400095375695131155222261304329
phenotype490725000954488127171214239277322362
LVOT45626200953672126162
VTI63626200954082101
(cm)75426200952255121141
PW1086262009540106
in121026200951659
A5C128726200954787132
~18–22186726200954881116158194233
–2862262009540
Monitor3535262009562106149166191233258
rhythm381026200952467102130173239
control353527200953677121145169212229
benefit378227200954484128167189207232
Before432326200954080102144169207
&4548262009544
after,46102620095365886124148159
CO432327200954697
Average490726200954781120144181226265
cycles519026200953573109126165196
Legend:45628400953366107141183223236
AA70728400954388
–810284009540
antiarrhythmic86528400954082105121161184207249281306347411427461
drug;134128400954063104145158
A4C151428400954380123
–1652284009540
apical17072840095418198132171188
four-chamber191028400952060101124146181222263326367401425
view;23502840095335084140154
A2C251928400954381123
–2657284009540
apical27122840095418198132171188
two-chamber291528400952381120146181223263327367402425
view;33552840095335084140154
A5C352428400954381122
–3661284009540
apical37162840095418198132171188
five-chamber39192840095203771105129165206246310350385408
view;43422840095345084140155
AUROC451228400954389128180224
–4751284009540
area48062840095406396137
under495828400954082122156180
the51532840095236498
receiver52662840095235690123140174207230
operating45629400954081116139177201217258299
characteristic76829400953475115138177210235268291308334358374407
curve11892940095337497133166
(*based13692940095215292133160194235
on161729400954082
an171329400954081
analysis180829400954082122139172200215242
of206429400954060
the21382940095236599
PRASE225029400953977121156190
study);24542940095285192133166185198
CW2665294009543109
–2788294009540
continuous-wave284129400953472114137153194235275316343365421461495529
Doppler;338329400955092133174191225248263
LVEF366029400953368103137
–3811294009540
left3865294009516507197
ventricular397629400953467108131154171204244261301325
ejection43142940095345085118143160200242
fraction;45692940095214583117141158198240253
E/e’48362940095356394107
–4957294009540
ratio50112940095236184101141
of516629400954060
transmi‑52402940095234785126153216232256
tral4563040095234685101
E572304009535
wave62130400955695130163
and79830400954082122
mitral93530400956380103126164181
annulus113030400954082123164180221248
e’139230400953447
wave;145430400955595129162176
AVTI164530400954380119136
–1795304009540
velocity18503040095336683123158174197233
time209730400952340103138
integral22493040095165880113154177215232
of249530400954061
A-wave;257030400954367124164198231245
LAEF283030400953378113147
–2991304009540
left3046304009516507197
atrial31583040095406386103143160
emptying333230400953498138162197213255295
fraction;36413040095214483116141157198240253
LA390830400953379
ESD400130400953570119
–4134304009540
left4189304009516507197
atrial43013040095406386103143160
end-systolic447530400953476116141168202230253292309326359
dimension;484930400954057120154196223238279320333
LAVi519730400953378115132
–5344304009540
left5398304009517517298
atrial4563140095406487103143160
volume6293140095347390131194229
index;8713140095165898132167182
LAP106631400953378116
–1195314009540
left1248314009516517298
atrial13593140095406386103143160
pressure;15323140095406396124151191214247261
LVOT180631400953369119153
VTI19723140095397895
–2080314009540
velocity21333140095346784124159175198233
time237931400952440104138
integral25303140095165880113154177215232
in277531400951657
left2845314009517517298
ventricular295631400953467108131154171204244261301325
outflow329431400954081104126145185241
tract;35483140095234685118143158
NOAF3719314009549101143178
–3910314009540
new-onset396231400954276132155198240266300324
atrial42993140095406386103143160
fibrillation;44723140095203778101118134151191214231271313326
PW4811314009538102
–4926314009540
pulsed-wave49793140095408198124158199223280320354387
Do‑537931400955091117
ppler;4563240095408198132156171
TR64232400953675
Vmax733324009540101142175
–924324009540
maximum980324009563104137154217258321
velocity13173240095346784124158175198233
of156632400954061
tricuspid1643324009523466396136163203220260
regurgitation;19193240095235696137160199216239278301317358400413
PLAX234732400953971116158
–2520324009540
parasternal257632400954081105143170193226249291331348
long-axis29403240095165798139163205239255282
view;32373240095345185140155
SR340832400953572
–3496324009540
sinus35523240095284384125152
rhythm;37193240095236597122163227240
ECV397532400953578119
–4110324009540
electrical41653240095345185119144167183217256273
cardioversion;44543240095337296134151192225259282310326366408421
TDI489132400953586103
–5009324009540
tissue5065324009524406694133167
Doppler524832400955091132174190225248
imaging;45633400951680120161178219259272
HR74333400954887
–845334009540
heart89933400954176116139165
rate;10783340095236285118132
sPAP122433400952865105143
–1381334009540
systolic14363340095286189112152168185219
pulmonary16693340095408198161202244284307343
artery20263340095406389122145180
pressure;22213340095406396124152191214247262
RV249733400953978
–2589334009540
right26443340095233980121144
ventricle;280233400953467108131154171204221255269
CO308533400954392
–3192334009540
cardiac32463340095347396135152192226
output.348633400954081104145186209223